Merging Microfluidics with Micro-titre Technology for More Efficient Drug Discovery

Area of Science:

• Biomedical Engineering
• Pharmacology
• Cellular Biology

Background:

• Current in vitro drug efficacy studies often lack the complexity to fully represent in vivo conditions.
• Rapid, multi-analyte detection from single red blood cell (RBC) samples is crucial for efficient drug response assessment.

Purpose of the Study:

• To develop and demonstrate a microfluidic device for rapid, simultaneous detection of multiple components within RBCs.
• To validate the device's utility in assessing drug efficacy, using iloprost as a model pharmaceutical.

Main Methods:

• An 18-well microfluidic array was designed to mimic in vivo blood circulation with controlled fluid flow.
• Multiple cell types were integrated onto the device for simultaneous analysis.
• Fluorescence microscopy was employed to quantify metabolite concentrations within RBCs.

Main Results:

• The microfluidic system successfully detected multiple components from a single RBC sample in under 20 minutes.
• Iloprost's effects on blood flow and cellular response were evaluated using the device.
• The system demonstrated potential for personalized medicine applications.

Conclusions:

• The developed microfluidic array offers a significant advancement for in vitro drug research by improving mechanistic studies.
• The device facilitates rapid, automated, and comprehensive analysis of RBCs, paving the way for personalized drug efficacy determination.